LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,187
تعداد مقالات10,824
تعداد مشاهده مقاله72,837,937
تعداد دریافت فایل اصل مقاله12,916,049
Jari, Maryam, Sadeghi allah abadi, Javad, Fathi, Davood, Attar, Marzieh, Maleki, Zahra, Shahbazi, Majid. (1401). Fibroblast Growth Factor-2 Levels are Elevated in The Serum of Patients with Multiple Sclerosis. سامانه مدیریت نشریات علمی, 19(2), 201-206. doi: 10.22034/iji.2022.94027.2275
Maryam Jari; Javad Sadeghi allah abadi; Davood Fathi; Marzieh Attar; Zahra Maleki; Majid Shahbazi. "Fibroblast Growth Factor-2 Levels are Elevated in The Serum of Patients with Multiple Sclerosis". سامانه مدیریت نشریات علمی, 19, 2, 1401, 201-206. doi: 10.22034/iji.2022.94027.2275
Jari, Maryam, Sadeghi allah abadi, Javad, Fathi, Davood, Attar, Marzieh, Maleki, Zahra, Shahbazi, Majid. (1401). 'Fibroblast Growth Factor-2 Levels are Elevated in The Serum of Patients with Multiple Sclerosis', سامانه مدیریت نشریات علمی, 19(2), pp. 201-206. doi: 10.22034/iji.2022.94027.2275
Jari, Maryam, Sadeghi allah abadi, Javad, Fathi, Davood, Attar, Marzieh, Maleki, Zahra, Shahbazi, Majid. Fibroblast Growth Factor-2 Levels are Elevated in The Serum of Patients with Multiple Sclerosis. سامانه مدیریت نشریات علمی, 1401; 19(2): 201-206. doi: 10.22034/iji.2022.94027.2275

Fibroblast Growth Factor-2 Levels are Elevated in The Serum of Patients with Multiple Sclerosis

Iranian Journal of Immunology
مقاله 8، دوره 19، شماره 2، شهریور 2022، صفحه 201-206    اصل مقاله (441.35 K)
نوع مقاله: Short Communication
شناسه دیجیتال (DOI): 10.22034/iji.2022.94027.2275
نویسندگان
Maryam Jari1؛ Javad Sadeghi allah abadi1، 2؛ Davood Fathi3، 4؛ Marzieh Attar1، 5؛ Zahra Maleki1؛ Majid Shahbazi* 1، 6
1Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran
2Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
3Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Science, Tehran, Iran
4Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
5Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran
6Arya Tina Gene Biopharmaceutical Company, Gorgan, Iran
چکیده
Background: Various factors contribute to the pathogenesis of Multiple Sclerosis (MS), one of which is Fibroblast Growth Factor 2 (FGF2). The function of FGF2 is pleiotropic. The investigation of the role of this factor in the myelination has produced conflicting results. Objective: To investigate the serum levels of FGF2 in patients with MS. Material and methods: Eighty patients with MS and eighty healthy volunteers with no history of inflammation or demyelinating disorders were included, and serum samples were collected to evaluate serum levels of FGF2 using the ELISA technique. Both groups had the same age and gender distribution. For analysis, the Mann-Whitney U test was used. Results: Patients with MS had considerably greater serum FGF2 levels than the control group (p = 0.005). There was no difference between the FGF2 level in men and women. Conclusion: Our data indicate that FGF2 levels may be related to the susceptibility of Iranian patients with MS. Further studies are required to analyze the involvement of FGF2 in enhancing the inflammatory process in MS.
کلیدواژه‌ها
Demyelination؛ ELISA؛ Fibroblast Growth Factor-2؛ Multiple Sclerosis؛ Serum
آمار
تعداد مشاهده مقاله: 1,033
تعداد دریافت فایل اصل مقاله: 561


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب